Although artificial intelligence (AI) has demonstrated potential in automating glaucoma screening, there is still a significant obstacle in transferring research datasets to actual clinical settings.
Akamai Technologies Inc. today announced new artificial intelligence-powered capabilities for its Guardicore Segmentation platform that are aimed at improving zero-trust security in hybrid and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results